Metabolome-wide Association Study of Bronchopulmonary Dysplasia in Extremely Premature Infants
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Rationale
Untargeted metabolomics may identify novel pathways involved in bronchopulmonary dysplasia (BPD), a poorly understood lung disease in extremely premature infants.
Objective
To identify metabolites and pathways altered in infants who develop BPD through a metabolome-wide association study.
Methods
We performed untargeted urinary metabolomics in 314 infants (<29 weeks gestational age) at two time points between postnatal days 5-15 and 23-32, with detailed time-series for 28 infants. We compared metabolite levels between infants with and without BPD at 36 weeks postmenstrual age using logistic regression and pathway enrichment analysis. A stratified analysis by nutrition type was performed at 23-32 days.
Results
Among the 913 analyzed urinary metabolites, 23 and 68 were nominally associated with BPD between postnatal days 5-15 and 23-32, respectively ( p <0.05). We found enrichment in the lactoyl amino acid sub-pathway (5-15 days; p =0.005, q =0.4) and xanthine metabolism and fatty acid metabolism (23-32 days; p≤ 0.002, q <0.1). Most BPD-differential metabolites were lower in infants with BPD at days 23-32 (OR=7.1, p =2×10 -6 ), with similar patterns among infants receiving parenteral (OR=9.2, p =7×10 -7 ) and full enteral nutrition (OR=6.1, p= 0.003). Twenty-four metabolites, including vitamins C, B 1 , and B 6 , were lower in infants on parenteral nutrition with BPD at postnatal days 23-32.
Discussion
BPD in extremely premature infants was associated with lower levels of vitamin-related metabolites and dysregulation of lactoyl amino acids, xanthine, and fatty acid metabolism. BPD-differential metabolites were lower in infants with BPD during the fourth week of life, potentially related to higher energy demand, metabolic dysregulation, insufficient nutrient availability, and/or impaired intestinal absorption.
What is already known on this topic:
Metabolic dysregulation has been implicated in bronchopulmonary dysplasia (BPD), but the metabolic pathways associated with BPD across early postnatal development remain poorly characterized. Existing metabolomic studies have been limited by small sample sizes and differences in biofluids, metabolomic approaches, and timing of sample collection, and no established metabolic biomarker exists for early diagnosis or monitoring of disease progression.
What this study adds:
In a large, two-cohort metabolome-wide study of extremely premature infants, BPD was associated with distinct metabolic patterns that varied by postnatal age and nutrition source, with enrichment of xanthine and fatty acid metabolism during the fourth week of life. BPD-differential metabolites were predominantly lower during the fourth week of life, particularly among infants still receiving parenteral nutrition.
How this study might affect research, practice or policy:
These findings identify metabolic and nutritional pathways for further investigation and may inform future studies of nutritional interventions aimed at reducing BPD risk in extremely premature infants.